• 2015 Sponsor
    CME L&C 2015
  • 2015 Sponsor
    Covington L&C 2015
  • 2015 Sponsor
    Davis Polk L&C 2015
  • 2015 Sponsor
    Foley L&C 2015
  • 2015 Sponsor
    IFM L&C 2015
  • 2015 Sponsor
    ICE L&C 2015
  • 2015 Sponsor
    Jenner & Block L&C 2015
  • 2015 Sponsor
    K&L Gates L&C 2015
  • 2015 Sponsor
    Milbank L&C 2015
  • 2015 Sponsor
    proskauer L&C 2015
  • 2015 Sponsor
    Schiff Hardin L&C 2015
  • 2015 Sponsor
    Stroock & Stroock & Lavan L&C 2015
  • 2015 Sponsor
    Willkie Farr L&C 2015
  • 2015 Sponsor
    wilmerHale L&C 2015
L&C 2010 Program
Thursday, April 29, 2010 at 2:00 PM
9. The Regulation of OTC Derivatives, Swaps Dealers and MSPs

Woodrow Wilson C/D

After providing a basic introduction to OTC derivatives, this session will discuss the evolving regulatory and legislative landscape for OTC derivatives, swap dealers and major swap participants. Issues will be addressed in connection with compliance requirements relating to swap dealers’ and MSPs' reporting obligations. The panel will also address legislative developments in connection with other duties imposed upon swap dealers and MSPs such as registration requirements, capital and margin requirements, the need for standards of conduct for risk disclosure and fair dealing, the application of making appropriateness or suitability determinations, and statutory disqualifications.


Moderator:
William McCoy, Managing Director, Morgan Stanley

Speakers:
Warren Davis, Of Counsel, Sutherland Asbill & Brennan
Armand Nakkab, Executive Director, Legal & Compliance, J.P. Morgan Chase
Ronald Oppenheimer, General Counsel, Vitol
Lawrence Patent, Of Counsel, K&L Gates
Athena Velie, Partner, McDermott Will & Emery

2001 Pennsylvania Avenue N.W.
Suite 600
Washington, D.C. 20006
Privacy Policy

Powered by KVENTURES
(202) 466-5460
(202) 296-3184 fax
www.futuresindustry.org